Story Highlight
- Averly Health is UK’s first integrated national cardiometabolic care provider.
- Joint venture between Reset Health and Pharmacy2U established Averly Health.
- Services support over two million patients monthly across the UK.
- Averly Health improves access and outcomes for chronic disease care.
- Integrated model reduces fragmentation in cardiometabolic care services.
Full Story
Averly Health has launched as the UK’s first integrated national cardiometabolic care provider, a joint venture between Reset Health and Pharmacy2U. This new initiative aims to enhance access and improve health outcomes for patients with chronic conditions such as obesity, type 2 diabetes, and cardiovascular disease. The company combines Reset Health’s clinical expertise in managing chronic diseases with Pharmacy2U’s advanced digital prescribing and pharmacy capabilities to create a seamless patient journey.
Averly Health focuses on providing a comprehensive service that streamlines the pathway from clinical assessment to long-term management and outcomes monitoring, significantly reducing the fragmentation currently faced by patients. Oliver McGuinness, Chief Executive Officer of Reset Health, remarked, “With the launch of Averly Health, we are proud to establish the UK’s most comprehensive cardiometabolic care service. This sets a new standard for accessible, scalable health services designed to expand access and transform care in every postcode.”
The joint venture aims to address existing challenges within the NHS by consolidating various services that patients typically navigate for cardiometabolic care. Josh Bottomley, Chief Executive Officer of Pharmacy2U, stated, “The NHS and other healthcare systems need practical ways to extend access to care while maintaining high standards of clinical quality, safety and patient experience.” Averly Health is designed to provide a coordinated experience that allows for better oversight of patient care and outcomes, ultimately improving overall healthcare access and adherence, particularly among vulnerable populations.
More than two million patients are already using the services and infrastructure that support Averly Health each month. The integrated model is designed to continuously collect data on patient engagement and outcomes, enabling NHS systems to illustrate the impact of the new service. This setup aims to support the delivery of care for patients prescribed GLP-1 medication, enhancing their weight management through behavioural support and clinical oversight.
Averly Health also aims to reduce health disparities by making cardiometabolic treatment more accessible to underserved populations. The initiative combines the financial and operational strengths of both founding companies, with a dedicated team prepared to meet local care needs while maintaining high standards in clinical governance. The offering represents a significant advancement in managing chronic diseases at a national scale.
Source: read the original report.
What this means for your site
The introduction of Averly Health marks a significant development in cardiometabolic care, yet it underscores the necessity for rigorous compliance with UK health and safety legislation. Specifically, the Health and Safety at Work etc. Act 1974 and the Management of Health and Safety at Work Regulations 1999 are directly applicable, emphasizing the requirement for organizations to safeguard the health and safety of both patients and staff. The fragmented system it replaces presents potential risks such as miscommunication, medication errors, and inadequate patient monitoring.
To mitigate these risks, healthcare providers should implement cohesive communication strategies across their teams and integrate comprehensive training focused on the new systems. Furthermore, establishing a robust data protection plan in accordance with the Data Protection Act 2018 ensures patient information management adheres to legal standards.
Regular audits of the integrated service’s operations can highlight areas requiring improvement, ensuring heightened clinical governance. Such proactive measures are essential to maintain patient safety and improve overall health outcomes across the NHS landscape.
